Influence of Quercetin Supplementation on Disease Risk Factors in Community-Dwelling Adults

Appalachian State University, Kannapolis, NC, USA.
Journal of the American Dietetic Association (Impact Factor: 3.92). 04/2011; 111(4):542-9. DOI: 10.1016/j.jada.2011.01.013
Source: PubMed


In vitro data indicate quercetin has antioxidative and anti-inflammatory functions with the potential to lower disease risk factors, but data in human beings are limited.
The objective of this study was to investigate the effect of quercetin, vitamin C, and niacin supplements (500 mg quercetin, 125 mg vitamin C, and 5 mg niacin [Q-500]; 1,000 mg quercetin, 250 mg vitamin C, and 10 mg niacin [Q-1,000]), on disease risk factors in a large group of community adults (n=1,002, 60% women) varying widely in age and body mass index.
Subjects were randomized into one of three groups (placebo, Q-500, or Q-1,000) and ingested supplements for 12 weeks. Blood samples were taken pre- and postsupplementation, and plasma quercetin, inflammatory markers (ie, C-reactive protein and five cytokines), diagnostic blood chemistries, blood pressure, and blood lipid profiles were measured.
Plasma quercetin increased in the Q-500 and Q-1,000 groups. No differences in blood chemistries were found except for a small decrease in serum creatinine and increase in glomerular filtration rate in Q-500 and Q-1,000 groups. A small decrease in mean arterial blood pressure was measured for Q-500 and Q-1,000 groups compared to placebo. A difference in serum total cholesterol was measured between Q-500 and placebo groups, and there was small decrease in high-density lipoprotein cholesterol levels in the Q-1,000 group. Change in inflammatory measures did not differ between groups except for a slight decrease in interleukin-6 for the Q-1,000 group.
Q-500 or Q-1,000 supplementation for 12 weeks had a negligible influence on disease risk factors.

Download full-text


Available from: David Christopher Nieman, Feb 17, 2015
  • Source
    • "quercetin in the mainstream was not related to any reduction in circulating cytokines. However, Knab [83] reported no effects on TNF-␣, but reduced levels of IL-6 concomitantly with increased concentrations of plasma quercetin. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological or in vitro evidence suggests a potential role for flavonoids as anti-inflammatory agents; we investigated the effect of flavonoids-rich foods or supplements on tumor necrosis factor- alpha (TNF-α) and interleukin-6 (IL-6) in long-term placebo-controlled human intervention trials. From 110 human intervention studies selected (MEDLINE, EMBASE, CHORANE, and FSTA databases), 32 long-term placebo-controlled trials were suitable for meta-analysis. After sensitivity analysis, seven studies imputed of bias were excluded and 25 studies were analyzed (TNF-α, n = 2404; IL-6, n = 2174). Levels of TNF-α decreased after flavonoid consumption in the fixed model only (mean difference (MD) (95% CI): -0.098 (-0.188, -0.009), p = 0.032), but metaregression results showed that neither higher dose, nor a longer duration of intervention were associated with a greater effect size. Subgroup analysis did not reveal any significant effect for quercetin and soy, but other sources (red wine, pomegranate, and tea extracts) showed a significant effect size both in fixed (MD (95% CI): TNF-α -0.449 (-0.619, -0.280), p < 0.001; IL-6 -0.346 (-0.612, -0.079), p = 0.011) and random (MD (95% CI): TNF-α -0.783 (-1.476, -0.090), p = 0.027; IL-6, -0.556 (-1.062, -0.050), p = 0.031) effect models. High-quality placebo-controlled trials are needed in order to identify flavonoids as the active ingredients.
    Full-text · Article · May 2013 · Molecular Nutrition & Food Research
  • Source
    • "F.T. Rosa et al. 2 Despite the number of human intervention studies that have evaluated quercetin as an anti-inflammatory supplement, almost all of them did not observe beneficial effects (Table I). Thus, Knab et al. (2011) proposed a high dose of quercetin (500 and 1000 mg) associated with vitamin C and niacin, but they did not find improvements on inflammation markers. Egert et al. (2009) were also not able to demonstrate marked different responses in hs-TNF-a in overweight/obese subjects, with traits of metabolic syndrome after a 150 mg of quercetin/day (d) supplementation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity and other chronic diseases are accompanied by adipose tissue, liver, pancreas, muscle and brain low-grade chronic inflammation. Indeed, the obese condition and metabolic syndrome are characterized by an increased expression of inflammatory cytokines and infiltration of immune cells in adipocytes. The inflammatory response promotes the activation of transcriptional factors and pro-inflammatory cytokines, which can lead to an unresolved inflammatory response associated with an inhibition of insulin signalling and high risk for cardiovascular events. Epidemiological and intervention studies have been carried out to find out dietary patterns, foods and bioactive compounds with protective anti-inflammatory actions. The most studied compounds are polyphenols, especially isoflavone and anthocyanin, but quercertin, catechin and resveratrol have also been investigated. Furthermore, some studies have reported the effects of milk peptides, plant sterol and stanol, l-carnitine and α-lipoic acid on inflammatory processes. This review aimed to collect and discuss those relevant studies reported in the scientific literature following a systematic scientific search about the effect of such bioactive compounds on inflammation in humans.
    Full-text · Article · Jan 2012 · International Journal of Food Sciences and Nutrition
  • Article: Quercetin

    No preview · Article · Jun 2011
Show more